Actionable news
0
All posts from Actionable news
Actionable news in FPRX: Five Prime Therapeutics, Inc.,

FIVE PRIME THERAPEUTICS INC director just picked up 6,090 shares

Franklin M Berger, a director of FIVE PRIME THERAPEUTICS INC, recently acquired 6,090 shares of the company. The buys took place at prices ranging from $46.74 to $47.23 per share, on April 19, 2016. Berger now owns 79,980 shares of the company. Berger operates out of South San Francisco, CA. Some additional info was provided as follows:

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $47.20 to $47.23, inclusive. The reporting person undertakes to provide to Five Prime Therapeutics, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1 and 2 to this Form 4. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $46.70 to $46.75, inclusive.

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever FIVE PRIME THERAPEUTICS INC makes a similar move, sign up!

Other recent filings from the company include the following:

President of FIVE PRIME THERAPEUTICS INC just cashed-in 1,405 options - April 18, 2016
President of FIVE PRIME THERAPEUTICS INC just cashed-in 2,725 options - April 15, 2016

President of FIVE PRIME THERAPEUTICS INC just cashed-in 52,801 options - April 7, 2016